Overview

Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research is to learn if an ultrasound contrast agent called OPTISON (perflutren protein type A) is effective in finding sentinel lymph nodes before surgery. Contrast agents can help make ultrasound images more accurate. The sentinel lymph node is the first node that may be the target of cancer cells that spread from the tumor.

Phase:

N/A

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

GE Healthcare